
IndraLab
Statements
Colchicine inhibits CASP1. 14 / 14
|
5
9
reach
"By immunofluorescence staining and other methods, Takuma Misawa et al. have successfully demonstrated that the assembly of not only NLRP3 and ASC but also NLRP3 inflammasomes into NLRP3 inflammasome complexes requires the transport function of microtubules.17 Because colchicine can inhibit the synthesis of microtubules and promote the degradation of microtubules, it can effectively inhibit the assembly of NLRP3 inflammasome complexes, and ultimately effectively inhibit the inflammatory response.3.2.3
Colchicine can effectively inhibit Caspase-1."
eidos
"As depicted in Figure 3 , compared with untreated FMF-derived PBMCs , DMAPT and colchicine significantly reduced LPS / ATP-induced NLRP3 ( 0.39 + / -0.12 , P < 0.001 and 0.31 + / -0.12 , P < 0.001 ) , MEFV ( 0.384 + / -0.145 , P < 0.001 and 0.332 + / -0.089 , P < 0.001 ) , CASP1 ( 0.48 + / -0.13 , P =0 .0023 and 0.37 + / -0.13 , P =0 .002 ) , and IL-1beta ( 0.09 + / -0.09 , P < 0.0001 and 0.42 + / -0.09 , P =0 .002 ) mRNA expressions ."
reach
"Whether colchicine inhibits caspase-1 at physiologic concentrations, or whether colchicine accumulation in leukocytes is sufficient to block the inflammasome, remains to be determined.Another mechanism by which colchicine may suppress inflammation is by inhibition of superoxide production by neutrophils."
| PMC